ramucirumab,pembrolizumab
eli lilly,Merck
['lcsm,(-blcsm)', 'lung', 'congrat', 'sclc', 'nsclc', 'improve', 'ramucirumab']
#asco22 #lcsm randomised ph2 of pembro + ramucirumab vs physicians choice soc chemotherapy in met #nsclc post io failure. impactful improvement in os,this is a new bar in refractory #lungcancer congrats! #onctwitter #cancerresearch 
Medical Oncologist. MA MD MRCP FRACP @uniofoxford @imperialcollege @rcplondon @theRACP Fellow @ucalgary